Moderna, Inc. (MRNA)
NASDAQ
Closed
Aug 21, 2026
Day's Range
132.4252 wk Range
22.28Overview - MRNA - Moderna, Inc.
Key Statistics
Valuation
Enterprise Value
49.37B
P/E (Trailing)
‪24.96‬
P/E (Forward)
‪-32.42‬
PEG Ratio
‪-3.32‬
Price / Sales (TTM)
‪26.62‬
Price / Book
‪8.76‬
EV / EBITDA
‪-22.49‬
Profitability
Gross Margin
‪34.96%‬
Profit Margin
‪-141.42%‬
Operating Margin
‪-557.93%‬
Return on Assets
‪-13.25%‬
Return on Equity
‪-38.99%‬
Ownership
Shares Outstanding
399.00M
Float
372.26M
Short % of Shares Outstanding
‪15.23%‬
Held by Insiders
‪7.31%‬
Held by Institutions
‪80.46%‬
Price stats
Beta
‪0.89‬
50-Day Avg
‪65.62‬
200-Day Avg
‪48.13‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
23 analysts
Average price target
‪$ 50.84‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MRNA - Moderna, Inc.
Peers - MRNA - Moderna, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- MRNANASDAQModerna, Inc.57.94BMarket Cap+82.53%52-week change24.97P/E (Trailing)‪-141.42%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt65.04BMarket Cap+34.86%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.60BMarket Cap-87.81%52-week change41.15P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE29.28BMarket Cap+9.87%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.61BMarket Cap+24.84%52-week change19.38P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.93BMarket Cap+41.98%52-week change-21.56P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.91BMarket Cap+12.29%52-week change180.16P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - MRNA - Moderna, Inc.
About
Moderna, Inc. is a biotechnology company specializing in the development of transformative medicines using messenger ribonucleic acid (mRNA) technology. Its primary focus lies in creating innovative therapeutics across multiple modalities, including prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
